Brief: Bajaj Healthcare Launches Posaconazole API Used In Treating Mucormycosis In COVID-19 Patients
28/05/2021 06:46
May 28 (Reuters) - Bajaj Healthcare Ltd BAJH.BO :
* LAUNCHES POSACONAZOLE API USED IN TREATING MUCORMYCOSIS IN
COVID-19 PATIENTS
Source text for Eikon: ID:nBSE35fhr7
Further company coverage: BAJH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bajaj Healthcare
See all newsIndia's Bajaj Healthcare falls on agreement to sell Gujarat undertaking for $1.5 million
Brief: Bajaj Healthcare June-Quarter Profit 137 Million Rupees
Brief: Bajaj Healthcare's Board Approves Sale Of Operational Business Unit At Tarapur
Brief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees